Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding

M. Chen, S. Narumiya, T. Masaki, T. Sawamura

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Lectin-like oxidized low-density-lipoprotein (oxLDL) receptor-1 (LOX-1) is a cell-surface endocytosis receptor for atherogenic oxLDL, which is highly expressed in endothelial cells. Recent studies suggest that it may play significant roles in atherogenesis. LOX-1 is a type-II membrane protein that structurally belongs to the C-type lectin family molecules. This study was designed to characterize the specific domain on LOX-1 that recognizes oxLDL. Truncation of the lectin domain of LOX-1 abrogated oxLDL-binding activity. Deletion of the utmost C-terminal ten amino acid residues (261-270) was enough to disrupt the oxLDL-binding activity. Substitutions of Lys-262 and/or Lys-263 with Ala additively attenuated the activity. Serial-deletion analysis showed that residues up to 265 are required for the expression of minimal binding activity, although deletion of the C-terminal three residues (268-270) still retained full binding activity. Consistently, these alterations in LOX-1 impaired the recognition by a functionally blocking monoclonal antibody for LOX-1. These data demonstrated the distinct role of the lectin domain as the functional domain recognizing LOX-1 ligand. The conserved C-terminal residues of lectin-like domain are essential for binding oxLDL. Particularly, the basic amino acid pair is important for the binding.

Original languageEnglish (US)
Pages (from-to)289-296
Number of pages8
JournalBiochemical Journal
Volume355
Issue number2
DOIs
StatePublished - Apr 15 2001

Fingerprint

Lipoprotein Receptors
Lectins
Lipoproteins
Class E Scavenger Receptors
oxidized low density lipoprotein
C-Type Lectins
Basic Amino Acids
Endothelial cells
Blocking Antibodies
Cell Surface Receptors
Endocytosis
Membrane Proteins
Substitution reactions
Atherosclerosis
Monoclonal Antibodies
Endothelial Cells

Keywords

  • Epitope mapping
  • Lectin-like oxidized LDL receptor-1
  • Monoclonal antibody

ASJC Scopus subject areas

  • Biochemistry

Cite this

Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding. / Chen, M.; Narumiya, S.; Masaki, T.; Sawamura, T.

In: Biochemical Journal, Vol. 355, No. 2, 15.04.2001, p. 289-296.

Research output: Contribution to journalArticle

@article{a5b3129e703947ee9079a29c6b98c5ad,
title = "Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding",
abstract = "Lectin-like oxidized low-density-lipoprotein (oxLDL) receptor-1 (LOX-1) is a cell-surface endocytosis receptor for atherogenic oxLDL, which is highly expressed in endothelial cells. Recent studies suggest that it may play significant roles in atherogenesis. LOX-1 is a type-II membrane protein that structurally belongs to the C-type lectin family molecules. This study was designed to characterize the specific domain on LOX-1 that recognizes oxLDL. Truncation of the lectin domain of LOX-1 abrogated oxLDL-binding activity. Deletion of the utmost C-terminal ten amino acid residues (261-270) was enough to disrupt the oxLDL-binding activity. Substitutions of Lys-262 and/or Lys-263 with Ala additively attenuated the activity. Serial-deletion analysis showed that residues up to 265 are required for the expression of minimal binding activity, although deletion of the C-terminal three residues (268-270) still retained full binding activity. Consistently, these alterations in LOX-1 impaired the recognition by a functionally blocking monoclonal antibody for LOX-1. These data demonstrated the distinct role of the lectin domain as the functional domain recognizing LOX-1 ligand. The conserved C-terminal residues of lectin-like domain are essential for binding oxLDL. Particularly, the basic amino acid pair is important for the binding.",
keywords = "Epitope mapping, Lectin-like oxidized LDL receptor-1, Monoclonal antibody",
author = "M. Chen and S. Narumiya and T. Masaki and T. Sawamura",
year = "2001",
month = "4",
day = "15",
doi = "10.1042/0264-6021:3550289",
language = "English (US)",
volume = "355",
pages = "289--296",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "2",

}

TY - JOUR

T1 - Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding

AU - Chen, M.

AU - Narumiya, S.

AU - Masaki, T.

AU - Sawamura, T.

PY - 2001/4/15

Y1 - 2001/4/15

N2 - Lectin-like oxidized low-density-lipoprotein (oxLDL) receptor-1 (LOX-1) is a cell-surface endocytosis receptor for atherogenic oxLDL, which is highly expressed in endothelial cells. Recent studies suggest that it may play significant roles in atherogenesis. LOX-1 is a type-II membrane protein that structurally belongs to the C-type lectin family molecules. This study was designed to characterize the specific domain on LOX-1 that recognizes oxLDL. Truncation of the lectin domain of LOX-1 abrogated oxLDL-binding activity. Deletion of the utmost C-terminal ten amino acid residues (261-270) was enough to disrupt the oxLDL-binding activity. Substitutions of Lys-262 and/or Lys-263 with Ala additively attenuated the activity. Serial-deletion analysis showed that residues up to 265 are required for the expression of minimal binding activity, although deletion of the C-terminal three residues (268-270) still retained full binding activity. Consistently, these alterations in LOX-1 impaired the recognition by a functionally blocking monoclonal antibody for LOX-1. These data demonstrated the distinct role of the lectin domain as the functional domain recognizing LOX-1 ligand. The conserved C-terminal residues of lectin-like domain are essential for binding oxLDL. Particularly, the basic amino acid pair is important for the binding.

AB - Lectin-like oxidized low-density-lipoprotein (oxLDL) receptor-1 (LOX-1) is a cell-surface endocytosis receptor for atherogenic oxLDL, which is highly expressed in endothelial cells. Recent studies suggest that it may play significant roles in atherogenesis. LOX-1 is a type-II membrane protein that structurally belongs to the C-type lectin family molecules. This study was designed to characterize the specific domain on LOX-1 that recognizes oxLDL. Truncation of the lectin domain of LOX-1 abrogated oxLDL-binding activity. Deletion of the utmost C-terminal ten amino acid residues (261-270) was enough to disrupt the oxLDL-binding activity. Substitutions of Lys-262 and/or Lys-263 with Ala additively attenuated the activity. Serial-deletion analysis showed that residues up to 265 are required for the expression of minimal binding activity, although deletion of the C-terminal three residues (268-270) still retained full binding activity. Consistently, these alterations in LOX-1 impaired the recognition by a functionally blocking monoclonal antibody for LOX-1. These data demonstrated the distinct role of the lectin domain as the functional domain recognizing LOX-1 ligand. The conserved C-terminal residues of lectin-like domain are essential for binding oxLDL. Particularly, the basic amino acid pair is important for the binding.

KW - Epitope mapping

KW - Lectin-like oxidized LDL receptor-1

KW - Monoclonal antibody

UR - http://www.scopus.com/inward/record.url?scp=0035871224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035871224&partnerID=8YFLogxK

U2 - 10.1042/0264-6021:3550289

DO - 10.1042/0264-6021:3550289

M3 - Article

C2 - 11284714

AN - SCOPUS:0035871224

VL - 355

SP - 289

EP - 296

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 2

ER -